Doctors Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.45 M
- Company Age 48 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 12.44%
- Profit Growth 107.79%
- Ebitda 884.46%
- Net Worth 3.56%
- Total Assets 3.36%
About Doctors Pharmaceuticals
Doctors Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 1976 and has a history of 48 years and nine months. Its registered office is in Unnao, Uttar Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Chandak, Anila Chandak, and Krishna Srivastava serve as directors at the Company.
Company Details
- Location Unnao, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110UP1976PTC004263
-
Company No.
004263
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 1976
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Doctors Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Chandak
|
Managing Director | 23-Mar-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anila Chandak
|
Director | 01-Jun-2022 | Current |
|
Krishna Srivastava
|
Director | 29-Sep-1997 | Current |
Financial Performance of Doctors Pharmaceuticals.
Doctors Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.44% increase. The company also saw a substantial improvement in profitability, with a 107.79% increase in profit. The company's net worth moved up by a moderate rise of 3.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctors Pharmaceuticals?
In 2021, Doctors Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Doctors Pharmaceuticals?
Unlock and access historical data on people associated with Doctors Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctors Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctors Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
